Participant List — Medications Development for Opioid Use Disorders and Overdose Prevention and Reversal
Cutting Edge Science Meeting Series to End the Opioid Crisis
Katherine L. Beebe, Ph.D.
Executive Vice President, Chief Development Officer
Titan Pharmaceuticals, Inc.
Andrew Bellinger, M.D., Ph.D.
Chief Scientific Officer, Lyndra Therapeutics
Anton Bespalov, M.D.
Co-Founder and Managing Partner
Partnership for Assessment and Accreditation of Scientific Practice
Robert Brooner, Ph.D.
Director, Addiction Treatment Services
Professor of Psychiatry and Behavioral Sciences
Johns Hopkins Medicine
Francis S. Collins, M.D., Ph.D.
Director
National Institutes of Health
U.S. Department of Health and Human Services
Roger Crystal, M.D.
Chief Executive Officer
Opiant Pharmaceuticals, Inc.
Kathryn Cunningham, Ph.D.
Chauncey Leake Distinguished Professor of Pharmacology; Vice Chairman, Department of Pharmacology; and Toxicology Director
Center for Addiction Research
The University of Texas Medical Branch
Gail D’Onofrio, M.D.
Professor of Emergency Medicine
Chair, Department of Emergency Medicine
Yale School of Medicine
Carlos Del Rio, M.D.
Professor of Medicine
Emory School of Medicine
Stephen Doberstein, Ph.D.
Senior Vice President and Chief Scientific Officer
Nektar Therapeutics
Elliot Ehrich, M.D.
Executive Vice President
Research and Development
Alkermes
Sergi Ferré, M.D., Ph.D.
Senior Investigator
Chief, Integrative Neurobiology Section
Intramural Research Program
National Institute on Drug Abuse
National Institutes of Health
Gary Fujii, Ph.D.
President & Chief Executive Officer
Molecular Express
Jeet Guram, M.D.
Chief Medical Officer
Centers for Medicare & Medicaid Services
U.S. Department of Health and Human Services
Christian Heidbreder, Ph.D.
Chief Scientific Officer
Indivior
Sharon Hertz, M.D.
Division Director
Division of Anesthesia, Analgesia, and Addiction Products
Food and Drug Administration
U.S. Department of Health and Human Services
Thomas J. Hudzik, Ph.D.
Senior Consultant
ALA BioPharma Consulting
Pedro Irazoqui, Ph.D.
Associate Head of Biomedical Engineering
Reily Professor of Biomedical Engineering
Showalter Faculty Scholar
Professor of Electrical and Computer Engineering
Director, Center for Implantable Devices
Weldon School of Biomedical Engineering
Purdue University
Kim Janda, Ph.D.
Ely R. Callaway, Jr. Professor of Chemistry
Professor
Director, Worm Institute for Research & Medicine
Skaggs Scholar, Skaggs Institute for Chemical Biology
Department of Chemistry Chemistry, Scripps Research Institute
Howard Levin, M.D.
President and Chief Scientific Officer
Coridea, LLC
Donald Mackenzie, Ph.D.
Vice President
Head, Global Formulation Development
GSK
Gary Matyas, Ph.D.
Chief, Adjuvants and Formulations
U.S. Military HIV Research Program
Walter Reed Army Institute of Research
Joe Menetski, Ph.D.
Deputy Director
Research Partnerships
for the National Institutes of Health Foundation
Seamus Mulligan
Chairman & Chief Executive Officer
Adapt Pharma
Amy Newman, Ph.D.
Deputy Scientific Director
Intramural Research Program
National Institute on Drug Abuse
National Institutes of Health
Jessica Hulsey Nickel
President & Chief Executive Officer, Addiction Policy Forum
Edward Nunes, M.D.
Professor of Psychiatry
Columbia University
S. Michael Owens, Ph.D.
Chief Scientific Officer, Professor, and Director, Center for Alcohol and Drug Abuse
Wilbur Mills Endowed Chair in Alcohol and Drug Abuse Prevention
University of Arkansas for Medical Sciences
Kinam Park, Ph.D.
Showalter Distinguished Professor of Biomedical Engineering
Professor of Pharmaceutics
Purdue University
Gavril Pasternak, M.D., Ph.D.
Anne Burnett Tandy Chair of Neurology
Memorial Sloan-Kettering Cancer Center
Paul Pentel, M.D.
Professor of Medicine
University of Minnesota
Daniele Piomelli, Ph.D., Pharm.D.
Professor of Anatomy & Neurobiology
Louise Turner Arnold Chair in Neurosciences
School of Medicine
University of California, Irvine
Colleen Ruegger, Ph.D.
Global Head of Oral Pharmaceutical Development
Novartis Pharmaceutical Corporation
Seddon Savage, M.D.
Adjunct Associate Professor of Anesthesiology
Geisel School of Medicine
Dartmouth College
Behshad Sheldon
President & Chief Executive Officer
Braeburn Pharmaceuticals
Lawrence A. Tabak, D.D.S., Ph.D.
Principal Deputy Director
National Institutes of Health
U.S. Department of Health and Human Services
Douglas Throckmorton, M.D.
Deputy Center Director for Regulatory Programs
Center for Drug Evaluation and Research
Office of Medical Products and Tobacco
Food and Drug Administration
U.S. Department of Health and Human Services
Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
National Institutes of Health
Sharon Walsh, Ph.D.
Professor, Behavioral Science
University of Kentucky College of Medicine
Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research
Food and Drug Administration
U.S. Department of Health and Human Services